In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Eli Lilly is stepping up its fight against copycat weight-loss drugs )
Also on site :
- Gold prices deepen losses, dropping below $3,300 per ounce
- Is Tesla on the Outs in China?
- LivePerson to Announce First Quarter 2025 Financial Results on May 7, 2025